Scholarly Works

Antifibrinolytics may be cost saving among recent...

Journal article

Antifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery.

Authors

Ray JG; Hamielec CM

Journal

Canadian Journal of Cardiology, Vol. 20, No. 8, pp. 829–830

Publication Date

June 1, 2004

ISSN

0828-282X

Associated Experts

Cindy Hamielec

Associate Clinical Professor, FHSMED

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3201 Cardiovascular medicine and haematology

Medical Subject Headings (MeSH)

Antifibrinolytic Agents Aspirin Clopidogrel Coronary Artery Bypass Cost-Benefit Analysis Drug Costs Humans Platelet Aggregation Inhibitors Randomized Controlled Trials as Topic Ticlopidine

Contact the Experts team

Get technical help

or

Provide website feedback